TMJ Bioengineering Conference

颞下颌关节（TMJ），或颌关节，是人体最复杂的关节之一。尽管患者数量巨大，且与过多TMJ疾病相关的发病率显著，但与骨科界感兴趣的关节相比，TMJ研究较少。与骨科界不同，TMJ研究界的工程师、科学家和临床医生之间没有组织上的连续性。为了应对这种明显缺乏协调开放的沟通，我们建议举行一次TMJ生物工程会议。TMJ生物工程会议定于2006年5月25日至27日在科罗拉多州博尔德附近举行。这次会议将是第一次，将病人和外科医生聚集在一起，向生物工程师提供具体的指导。会议的总体目标是为生物工程师提供一个独特的论坛，与临床医生和患者交流想法和观点，以确定治疗TMJ疾病的当代挑战，并制定战略，以解决这些挑战与生物工程。这一目标将通过以下具体目标来实现：1）从临床社区获得生物工程指令， 2)将患者群体代表确定的需求纳入这些生物工程指令，以及3）为当前最先进的治疗和科学知识设定基准。我们已经选择了外科医生和患者的首要群体来发布目标1和目标2的指令。美国颞下颌关节外科医生协会主席将根据其年会上制定的优先问题共识发表主旨演讲，而颞下颌关节协会患者组织主席将根据以前的会议和数十年的经验以及与颞下颌关节患者的互动发表主旨演讲。当代颞下颌关节知识的基准将由38 在组织工程学、生物力学、生物学和临床治疗方面的会议上发言。这些指令的传播和突出讨论的摘要将在一篇文章中刊登，该文章将发表在生物医学工程年鉴上，这是主要生物工程专业协会的官方杂志，生物医学工程协会。有迫切需要本次会议，这将设置阶段不仅为未来的TMJ特定的生物工程会议，但也将作为一个里程碑式的扩展TMJ研究通过发展连续性，促进合作，并吸引更多的人才到该领域。

The temporomandibular joint (TMJ), or jaw joint, is one of the most complex joints in the body. Despite the tremendous patient population and the significant morbidity related to a plethora of TMJ disorders, the TMJ has been poorly studied in comparison to joints of interest to the orthopaedic community. Unlike the orthopaedic community, there is no organized continuity between engineers, scientists and clinicians in the TMJ research community. In response to this striking lack of coordinated open communication, we are proposing to hold a TMJ Bioengineering Conference. The TMJ Bioengineering Conference is scheduled for May 25-27, 2006 near Boulder, CO. This meeting will be the first of its kind, bringing patients and surgeons together to deliver specific directives to bioengineers. The overall meeting objective is to provide a unique forum for bioengineers to exchange ideas and perspectives with clinicians and patients, in an effort to identify contemporary challenges with treating TMJ disorders and to devise strategies to address these challenges with bioengineering. This objective will be addressed by the following Specific Aims: 1) To obtain bioengineering directives from the clinical community, 2) To incorporate into these bioengineering directives needs as identified by representatives of the patient population, and 3) To set a benchmark for current state-of-the-art treatments and scientific knowledge. We have selected the premiere groups of surgeons and patients to issue the directives of aims 1 and 2?the president of the American Society of TMJ Surgeons will deliver a keynote address based on a consensus of priority issues formulated at their annual meeting, and the president of the TMJ Association patient organization will deliver a keynote address based on previous meetings and decades of experience and interaction with TMJ patients. A benchmark for contemporary knowledge of the TMJ will be assessed by 38 speakers in sessions on tissue engineering, biomechanics, biology and clinical treatment. Dissemination of these directives and a summary of salient discussions will be featured in an article that will go to the Annals of Biomedical Engineering, the official journal of the main bioengineering professional society, the Biomedical Engineering Society. There is a compelling need for this conference, which will set the stage not only for future TMJ-specific bioengineering meetings, but will also serve as a milestone expansion in TMJ research by developing continuity, fostering collaborations, and drawing more talent to the field.